Herspiegel Consulting is known for our expertise in identifying education gaps, raising awareness of the science underlying disease states, and speeding translation of this information to clinical practice through comprehensive learning opportunities. We develop innovative medical education activities, expertly tailored to fulfill the needs of diverse, sophisticated clinical audiences and diligently monitored to facilitate continuous growth and improvement.
Assessed education gaps, aligned with portfolio strategy, and developed medical objectives and strategic plans.
Built a comprehensive and well referenced resource of medical messages with correlated supportive data.
Developed an asset specific resource that compiles cross-functionally aligned terms and phrases to inform internal and external communication activities.
Identified disease and clinical experts to advise on medical strategy and engaged qualified speakers for medical education events.
Planned and executed meetings with thought leaders to identify insights and strategic direction.
Derived short- and long-term market shaping strategic planning to raise awareness of new disease/MOA, amplify unmet needs, and reach target audiences.
The FDA is developing a framework for a new Real-World Evidence (RWE) Program to guide the generation of data in support of approval for in-line indications. Read our white paper to learn how the pharmaceutical industry will be impacted.